The survival association of CD3+CD8+EOMES−PD-1− T cells, which were demonstrated above to be the best immune parameter predictive for long-term survival in ICC, is different between tumor areas and peripheries. The gene discussed is CD8A; the disease is intrahepatic cholangiocarcinoma.